MEDRYSONE

SynDRA canonical compound SYN0023447 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · OTC
Primary target(s)	NR3C1
Mechanism of action	Glucocorticoid receptor agonist
Indication	conjunctivitis \| conjunctivitis, episcleritis \| episcleritis
Disease area	ophthalmology

All known targets

hydroxymesterone
medrifar
medrocort
Medrisona
Hydroxymesterone
NSC-63278
U-8471
Medrifar
Medritonic
Medrocort
Visudrisone
Medrysone (USAN)
(6S,8S,9S,10R,11S,13S,14S,17S)-17-acetyl-11-hydroxy-6,10,13-trimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
11.beta.-Hydroxy-6.alpha.-methylpregn-4-ene-3,20-dione
11.beta.-Hydroxy-6.alpha.-methylprogesterone
11beta-Hydroxy-6alpha-methyl-4-pregnene-3,20-dione
11beta-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione
6.alpha.-Methyl-11.beta.-hydroxyprogesterone
U 8471
NSC 63278
D2UFC189XF
6-alpha-Methyl-11-beta-hydroxyprogesterone
DTXCID4025371
NSC63278
HMS suspension
RefChem:55563
HMS Liquifilm
6alpha-Methyl-11beta-hydroxyprogesterone
GSH 1043
MLS000028714
MLS001076155
SMR000058693
MEDRYSONE [USAN]
Medriabioptal
Medrysonum
Sedesterol
Spectramedryn
(6alpha,11beta)-11-hydroxy-6-methylpregn-4-ene-3,20-dione